Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801
Phone :
+1-415-463-3094
Email :
anishagadia@hidoc.co
Published Date: 27 Apr 2023
In the second week of life, 83 percent of newborns who were fed formula milk had Clostridium difficile and Clostridium perfringens, but by the end of the third week, all infants had these infections.
Read Full NewsA randomized trial questions whether patients with standard-risk multiple myeloma need indefinite lenalidomide maintenance.
A phase 2 trial evaluates the benefit of adding blinatumomab to consolidation therapy in adults with high-risk Philadelphia chromosome-negative B-cell acute lymphoblastic leukemia.
1.
Cardiorespiratory fitness lowers the risk of colon, lung, and prostate cancer in MEN and lowers mortality from these diseases.
2.
Biomarker panel offers hope for early pancreatic cancer detection
3.
Reducing social media to an hour a day boosts young people's self-image.
4.
Experts Debate AQUILA Trial Findings in Smoldering Multiple Myeloma
5.
Novel Agent for Chronic GVHD Wins FDA Approval
1.
Role of Type I Interferons and KDM1B in Driving Cancer Stemness and Therapeutic Evasion
2.
AI Revolutionizes Immunotherapy: Unveiling Biomarkers with Machine Intelligence
3.
Leukemia: Understanding the Disease and Its Impact on Patients
4.
The importance of understanding normal serum osmolality
5.
Chondroma: What it is and How it Affects Your Health
1.
Asian Symposium on Advancement in Hematology and Oncology
2.
Asian Symposium on Advancement in Hematology and Oncology
3.
Asian Symposium on Advancement in Hematology and Oncology
4.
International Cancer Conference
5.
Asian Symposium on Advancement in Hematology and Oncology
1.
Learning About Different Treatment Approaches For Acute Lymphoblastic Leukemia
2.
Breaking Ground: ALK-Positive Lung Cancer Front-Line Management - Part I
3.
Understanding the Multifaceted Advantages of CDK4/6 Inhibitors in HR+/HER2- PALOMA 2 Study.
4.
Incidence of Lung Cancer- An Overview to Understand ALK Rearranged NSCLC
5.
Updates on Standard V/S High Risk Myeloma Treatment
Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801
Phone :
+1-415-463-3094
Email :
anishagadia@hidoc.co
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
To get started please enter your email ID
Join to enhance your clinical skills and gain specialized in-depth medical knowledge